Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Aug 11, 2014	EDAP Schedules Webcast and Conference Call for Second Quarter 2014 Results LYON, France , Aug. 11, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2014 results announcement, which will take place on August 28, 2014 , before the opening of the market.	View HTML EDAP Schedules Webcast and Conference Call for Second Quarter 2014 Results 15.8 KB
Toggle Summary Aug 05, 2014	EDAP Comments on FDA Panel Vote Responds to Gastroenterology and Urology Devices Panel Vote on Ablatherm-HIFU for Treatment of Prostate Cancer LYON, France , Aug. 5, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today provided comments on the recent Gastroenterology and Urology	View HTML EDAP Comments on FDA Panel Vote 17.2 KB
Toggle Summary Jul 30, 2014	EDAP Updates on FDA Advisory Committee Meeting on Ablatherm-HIFU for the Treatment of Prostate Cancer LYON, France , July 30, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the U.S. Food and Drug Administration's (FDA) Gastroenterology and Urology Devices Panel (GUDP) voted 3 yes, 5 no with 1 abstention on the question of	View HTML EDAP Updates on FDA Advisory Committee Meeting on Ablatherm-HIFU for the Treatment of Prostate Cancer 16.5 KB
Toggle Summary Jun 27, 2014	EDAP Completes FDA Inspection of Manufacturing Site FDA Inspector Reported no Findings From the Scheduled Facility Audit	View HTML EDAP Completes FDA Inspection of Manufacturing Site 14.9 KB
Toggle Summary Jun 03, 2014	EDAP Closes $9.3 Million Registered Direct Offering Positions Company to Advance on Preparing U.S. Operations in Connection with FDA Advisory Committee Meeting and PMA process	View HTML EDAP Closes $9.3 Million Registered Direct Offering 13.9 KB
Toggle Summary May 28, 2014	EDAP to Raise $9.3 Million in Registered Direct Offering LYON, France , May 28, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced that it has entered into definitive agreements with certain institutional investors for a registered direct placement of 3 million of ordinary shares in the form of	View HTML EDAP to Raise $9.3 Million in Registered Direct Offering 16.7 KB
Toggle Summary May 27, 2014	EDAP Outlines Key Events Scheduled in the Ablatherm-HIFU PMA Process LYON, France , May 27, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today provided additional details on key events scheduled as part of the U.S. Food and Drug Administration (FDA) Pre-Market Approval ("PMA") process for its Ablatherm-HIFU device	View HTML EDAP Outlines Key Events Scheduled in the Ablatherm-HIFU PMA Process 15.9 KB
Toggle Summary May 22, 2014	EDAP's Ablatherm-HIFU FDA Panel Meeting Confirmed for July 30, 2014 LYON, France , May 22, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the U.S. Food and Drug Administration (FDA) Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee will review the Pre-Market	View HTML EDAP's Ablatherm-HIFU FDA Panel Meeting Confirmed for July 30, 2014 15.1 KB
Toggle Summary May 16, 2014	EDAP Highlights Its HIFU and Lithotripsy Technologies at 109th Annual AUA Meeting Receives Outstanding Poster Designation for Ablatherm-HIFU	View HTML EDAP Highlights Its HIFU and Lithotripsy Technologies at 109th Annual AUA Meeting 17.2 KB
Toggle Summary May 15, 2014	EDAP Reports First Quarter 2014 Results - All Time Record High First Quarter Revenue and Positive Operating Income - Highlights Record revenue of EUR 7.8 million for the first quarter 2014, a 31% year-over-year increase First quarter 2014 gross margin up nine points to 46% Second sequential quarter with positive operating income	View HTML EDAP Reports First Quarter 2014 Results 32.8 KB